Evaluation of the efficacy of a novel Vibrio vulnificus vaccine based on antibacterial peptide inactivation in turbot, Scophthalmus maximus.
Evaluation of the efficacy of a novel Vibrio vulnificus vaccine based on antibacterial peptide inactivation in turbot, Scophthalmus maximus.
复制标题
DOI:
10.1016/j.fsi.2021.09.008
复制
发表时间:
2021-09
影响因子:
4.7
通讯作者:
Qin-Qin Gu-Qin;Guang-hua Wang;Ningqiu Li;Dongfang Hao;Hongmei Liu;Chang-biao Wang;Yong-hua Hu;M. Zhang
中科院分区:
文献类型:
--
作者:
Qin-Qin Gu-Qin;Guang-hua Wang;Ningqiu Li;Dongfang Hao;Hongmei Liu;Chang-biao Wang;Yong-hua Hu;M. Zhang
Tongue sole tissue factor pathway inhibitor 2 (TFPI-2) C-terminus derived peptide, TC38, has previously been shown to killVibriovulnificuscells without lysing the cell membrane; thus, the remaining bacterial shell has potential application as an inactivated vaccine. Therefore, this study aimed to evaluate the immune response induced by the novelV. vulnificusvaccine. The protective potential of TC38-killedV. vulnificuscells (TKC) was examined in a turbot model. Fish were intramuscularly vaccinated with TKC or FKC (formalin-killedV. vulnificuscells) and challenged with a lethal-dose ofV. vulnificus. The results showed that compared with FKC, TKC was effective in protecting fish againstV. vulnificusinfection, with relative percent of survival (RPS) rates of 53.29% and 63.64%, respectively. The immunological analysis revealed that compared with the FKC and control groups, the TKC group exhibited: 1) significantly higher respiratory burst ability and bactericidal activity of macrophages at 7 d post-vaccination; 2) increased alkaline phosphatase, acid phosphatase, lysozyme, and total superoxide dismutase levels post-vaccination; 3) higher serum agglutinating antibody titer with corresponding higher serum bactericidal ability, and a more potent serum agglutination effect, as well as an increased IgM expression level; 4) higher expression of immune relevant genes, which were involved in both innate and adaptive immunity. Taken together, this is the first study to develop a novelV. vulnificusinactivated vaccine based on AMP inactivation, and TKC is an effective vaccine againstV. vulnificusinfection for aquaculture.